BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma

BACKGROUND: Nonfunctioning pituitary adenoma (NFPA) and growth hormone pituitary adenoma (GHPA) are major subtypes of pituitary adenomas (PAs). The primary treatment is surgical resection. However, radical excision remains challenging, and few effective medical therapies are available. It is urgent...

全面介紹

Na minha lista:
書目詳細資料
發表在:Neuro Oncol
Main Authors: Shi, Chengzhang, Ye, Zhao, Han, Jie, Ye, Xiaoqing, Lu, Wenchao, Ji, Chenxing, Li, Zizhou, Ma, Zengyi, Zhang, Qilin, Zhang, Yichao, He, Wenqiang, Chen, Zhengyuan, Cao, Xiaoyun, Shou, Xuefei, Zhou, Xiang, Wang, Yongfei, Zhang, Zhaoyun, Li, Yiming, Ye, Hongying, He, Min, Chen, Hong, Cheng, Haixia, Sun, Jun, Cai, Jianyong, Huang, Chuanxin, Ye, Fei, Luo, Cheng, Zhou, Bing, Ding, Hong, Zhao, Yao
格式: Artigo
語言:Inglês
出版: Oxford University Press 2020
主題:
Basic and Translational Investigations
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594556/
https://ncbi.nlm.nih.gov/pubmed/32246150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa084
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍